Bret Jensen's  Instablog

Bret Jensen
  • on Healthcare
Send Message
Editor for The Biotech Forum, the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune... More
My company:
My blog:
Biotech Forum
  • Time to BID farewell to Sotheby's? 0 comments
    Apr 6, 2010 7:40 PM | about stocks: BID
    Overview: Sotheby’s, together with its subsidiaries, operates as an auctioneer of fine and decorative art, jewelry, and collectibles primarily in the United States, the United Kingdom, China, and France. The company operates in three segments: Auction, Finance, and Dealer.
    Valuation: Sotheby’s has more than quintupled off its lows of the market nadir of March 2009. It trades at approximately 35 times this fiscal year’s consensus earnings of 95 cents a share and 25 times next year’s consensus earnings of $1.42. It also trades at 4.5 trailing revenues and a five year high of price to cash flow and 4 times book value. It had negative operating cash flow in 2007 and 2008.
    Key Red Flags:We are concerned for several reasons about the near term prospects for stock price appreciation for BID:
    1.       This has been a very cyclical stock over the last six years. It has had earnings ranging from $3.25 in 2007 to a negative 10 cents in 2009. 35 times projected earnings and/or 10 times peak earnings seem like an excessive amount to pay for a stock with this type of earnings variance.
    2.       Insiders have sold approximately 40% of their total shares over the last six months
    3.       The stock is selling for 25 times its average earnings over the previous six fiscal years
    Technical outlook: BID is trading over 40% its 200 day moving average 
    Price Target: Given the cyclical nature of this company’s business model, 12-15 times next year’s earnings of $1.42 seem like a more reasonable valuation. Price target of $17-$22.
    Conservative to Medium risk investors: Avoid
    High Risk investors: Short
    Very aggressive traders: Sell Jan 11 35 naked calls at $4.50. 

    Disclosure: Short BID
    Stocks: BID
Back To Bret Jensen's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $THLD Definitely worthy of consideration for the SmallCapGems ( portfolio
    Dec 27, 2014
  • $OGXI. Looks like this possible SmallCapGem ( is heading to a much better year in 2015.
    Dec 26, 2014
  • Navidea Pharmaceuticals: An Update On My $2 Biotech Lottery Ticket $NAVB
    Dec 23, 2014
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.